Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PCSK9 inhibitors for acute coronary syndrome: the era of early implementation
Hongzhen Chen, Xiaomin Chen
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16

Showing 16 citing articles:

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
Maciej Banach, Stanisław Surma, Peter P. Tóth
Archives of Medical Science (2023)
Open Access | Times Cited: 28
The Effect of PCSK9 Monoclonal Antibodies on Platelet Reactivity and Cardiovascular Events in Patients Receiving Primary Percutaneous Coronary Intervention: A Propensity Score-Matched Analysis
Yao Yao, Qining Qiu, Zi Wang, et al.
American Journal of Cardiovascular Drugs (2025)
Closed Access
Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases
Mojgan Nejabat, Farzin Hadizadeh, Wael Almahmeed, et al.
Drug Discovery Today (2025), pp. 104316-104316
Closed Access
Real-world management of hypercholesterolemia in patients after acute coronary syndrome in Greece
Despoina Massia, Periklis Giovas, Nikolaos Papadopoulos, et al.
Atherosclerosis Plus (2025)
Open Access
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy
Chou‐Yi Hsu, Mustafa Nasrat Abdulrahim, Mohammed Ahmed Mustafa, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 3
The Link between miRNAs and PCKS9 in Atherosclerosis
Mirjana Mačvanin, Zoran Gluvić, Aleksandra Klisić, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 42, pp. 6926-6956
Closed Access | Times Cited: 7
Novel PCSK9 Inhibitors for Treating Cardiovascular Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 4, pp. 443-444
Open Access | Times Cited: 2
Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study
Yinsong Xu, Y. Li
World Allergy Organization Journal (2024) Vol. 17, Iss. 4, pp. 100899-100899
Open Access | Times Cited: 2
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance
Yajnavalka Banerjee, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108517-108517
Closed Access | Times Cited: 6
PCSK9 inhibitor in acute ischemic stroke patient receiving mechanical thrombectomy: early outcomes and safety
Jonguk Kim, Uichan Hong, Cindy W. Yoon, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
Kaveh Hosseini, Hamidreza Soleimani, Saba Maleki, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Prospects of Using PCSK9 Inhibitors for Acute Coronary Syndrome
А. М. Намитоков, В. К. Зафираки, K. V. Karabakhtsieva
Innovative medicine of Kuban (2024), Iss. 2, pp. 124-128
Open Access
Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease
Tatjána Ábel, Béla Benczúr, Éva Csajbókné Csobod
Frontiers in Medicine (2024) Vol. 11
Open Access
La importancia de la unidad de dolor torácico virtual en el área hospitalaria
Ricardo Cruz-Silva, Jhonattan D. Castro-Pérez, David O. Esparza-Hernández, et al.
Anales Médicos de la Asociación Médica del Centro Médico ABC (2024) Vol. 69, Iss. 2
Open Access
Molecular cardiopharmacology and therapeutics-II
Akkiraju Sudheer, Charitha Bandlapalli, D. S. N. B. K. Prasanth, et al.
Elsevier eBooks (2024), pp. 487-502
Closed Access
Safety and efficacy of PCSK9 inhibitors and effect on coronary plaque phenotype in statin-treated patients following acute coronary syndrome: a systematic review and meta-analysis
Dennis Ievan Hakim, Faqrizal Ria Qhabibi, Muhammad Yusuf, et al.
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access
Page 1

Scroll to top